Home of the World's Most Influential Journalists

 

                  

 

 

 




Blogging NewsBios


Enter Your Email Below

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our E-Briefing

ORDER HERE

New Pricing Effective 2011

 Search for a Profile:

A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z
 

 

Home

Pricing/Ordering 

FREE NEWSLETTER

Existing Profiles 

Why our Profiles?

FREE NEWSBIOS ON DEMAND

30 Under 30

Client Testimonials

Journalist Comments

Media Outlets

Exclusive Journalists' Interviews

Blogging NewsBios

The World's Most Influential
Health & Medical Journalists

BLOG TOPICS:

John Acher - Reuters 

Cristina Alesci - Bloomberg

Rob Cox - Breakingviews


Automotive Writers  

Julia Boorstin - CNBC

Jessica Hall - Reuters

Bob Herbert - NYT

Rob Schmitz - KQED


Wash Post Journalists Discover a Resilient USA

Time's Alice Park - Health Journalist of the Month

Coverage of Peanut Butter Recall: Gardiner Harris

FT's Andrew Jack Has the Scoop on Sanofi-Aventis

Health Journalism Today

Recently Updated health.newsbios*:

Associated Press:

• Linda A. Johnson
• Lauran Neergaard
• Matthew Perrone

Bloomberg News:

• Kristen Hallam
• John Lauerman
• Elizabeth Lopatto
• Shannon Pettypiece
• Tom Randall
• Lisa Rapaport
• Albertina Torsoli
• Angela Zimm

BusinessWeek:

• Catherine Arnst
• Arlene Weintraub

Dow Jones Newswire:

• Jennifer Corbett-Dooren
• Jared A. Favole
• Peter Loftus

Financial Times:

• Andrew Jack

Forbes:

• Matthew Herper
• Robert Langreth

New York Times:

• Reed Abelson
• Gardiner Harris
• Robert Pear
• Natasha Singer
• Duff Wilson


Reuters:

• Bill Berkrot
• Susan Heavey
• Lewis Krauskopf
• Ransdell Pierson
• Lisa Richwine

Wall Street Journal:

• John Carreyrou
• Vanessa Fuhrmans
• Jacob Goldstein
• Avery Johnson
• Anna Wilde Mathews
• Alicia Mundy
• Jonathan D. Rockoff
• Shirley S. Wang
• Jeanne Whalen
• Ron Winslow
• Jane Zhang

Other:

• Susan Dentzer, Health Affairs, Editor-in-Chief
• Katherine Eban, Freelance Investigative Health Care Reporter/ABC News
• Mike Huckman, Pharmaceutical Reporter, CNBC
• Alice Park, Senior Writer, TIME
• Bernadette Tansey, Staff Writer, San Francisco Chronicle

* Dozens of additional health.newsbios also available. Call for details.

Media Strategies Workshops and Dean Rotbart's Newsroom Confidential Column or CLASSROOM Edition.

 

 Tote Bag

Buy Cool Stuff!



 

Mr. Greed Meet Mr. Rockefeller


The News Media Owe Mike Milken Three Simple Words, But He Is Unlikely To Ever Collect, Nor To Really Care

By Dean Rotbart

BEVERLY HILLS - Few in the news media ever have the integrity and guts to say publicly,
"I was wrong."

If they did, I believe a long cue of reporters, editors, columnists and other self-appointed pundits would be lining up outside of Michael Milken's nearby headquarters, clearing their throats and trying desperately to spit out those three words like some flying insect they accidentally ingested while yammering at an outdoor barbecue.

 Milken, as most of you will remember, is the dethroned Junk Bond King of the 1980s who was universally pilloried as an icon of greed. Indeed, Rudy Gulliani's successful prosecution of Milken in 1989 on six obscure securities law violations landed Gulliani in the New York City's mayor's office and Milken in a federal penitentiary for almost two years.

The extent of Milken's crimes, if there ever were really any crimes, were far overshadowed by the public contempt for him and his band of wealthy CEO clients. Using innovative financing, Milken generated the capital necessary to create and grow dozens of name brand corporations (MCI, McCaw Cellular, CNN, etc.) and in the process created hundreds of thousands of jobs.

Milken also bitch slapped the blue blooded establishment of investment banks, securities firms, pension fund managers and insurance companies, all of whom cried foul to their powerful friends and campaign contribution recipients in Washington.

Most journalists covering Milken were far too shallow to explore the political and business interests that benefited from his prosecution and expulsion from the industry. Rather, the news media embraced the stereotype of "greedy Mike" and created such a hue and cry for his beheading that the government had little choice but to oblige.

I remember writing about the media coverage of Milken as early as 1987 and expressing deep reservations over the pack mentality of the press. Why Milken finally pleaded guilty I don't know. I do know that Gulliani was threatening to prosecute his brother and possibly other family members and I suspect Milken was realistic enough to know that only a "guilty" plea would end his long, long ordeal. Which it finally did.

But as with most media stereotypes, time has demonstrated amply that Mike Milken isn't the man the media portrayed. Mr. Greed, it turns out, had always been a philanthropist and is today one of the nation's leading philanthropists (ahead of the Rockefeller brothers).

More than just his money, Milken is using his unique genius and charisma to do a lot of good. Among his most important projects: the effort to cure some of our most dreaded illnesses, notably cancer and heart disease.

Milken, who refocused his energies from money making to life saving, was undoubtedly influenced by his own diagnosis of prostrate cancer. Today, he is a leading catalyst for the funding of medical research, creating new pro-health government regulation, and for unifying for-profit, non-profit and government groups in the creative search for cures and preventions.

I was recently a first hand witness to the respect and admiration afforded Milken by some of the nation's leading medical luminaries and researchers. Their appreciation for his efforts - both financial and as a powerful health lobbyist - was both obvious and obviously genuine.

Dr.David Kessler          


Among those who took the time to participate in Milken's 5th annual Milken Institute Global Conference, presented by his non-profit think tank, were: David Kessler, Dean of the Yale School of Medicine and former FDA commissioner; Andrew C. von Eschenbach, director of the National Cancer Institute; S. Ward Casscells, Chief of Cardiology at the University of Texas Health Science Center; David Heber, director of the UCLA Center for Human Nutrition; and Dean Ornish, author and President, Preventive Medicine Research Institute at the University of California, San Francisco.

Dr. Dean Ornish

Other panelist at Milken's three-day conference included multiple Nobel laureates, previous Presidential candidates, ex-Cabinet members, leading Forbes 500 CEOs, distinguished journalists, the President's brother and a whole bunch of heavyweight thinkers and doers.

It is not the friends Mike Milken has that validate his worth. It is the friendships. These influencers speak of him out of admiration and sincerity, not financial interest or obligation.

I believe Milken not only disproved his media critics long ago, he made them irrelevant then, now and in the future. It is doubtful that anyone alive has been the subject of as much media bashing as Mike Milken. Yet, he stands today as an undeniable proof that the media don't control the world and what they say doesn't make a damned bit of difference unless you permit it to. Remember that lesson the next time your name is dragged through the mud! 

 April 29, 2002

 

Back to Article Archives    Newsroom Confidential Home 

Guest Archives

 








The Journalist's Store




Site Sponsors Include:

Best Journalism Schools
Editor-in-Chief.com
Hopeless Utopian

NewsBios-on-Demand


 


 

POWERED BY: You, Here, Now!

Home Page      Newsroom Confidential Home    Order Form    About Us    About TJFR   

Guest Column Archives   Newsroom Confidential Archives

 

Hit Counter

        A Division of the TJFR Group, Inc.

        2020 Arapahoe Street/Lower Level

        Denver, CO 80205

        P:  1.866.NEWS.070 ext. 2  F:  720.528.7821

        E:  TJFR@NewsBios.com

Last modified: February 12, 2010                  

Copyright © 2011  NewsBios                                                                                                                            

 

All copyright, content and publishing are solely proprietary rights of the TJFR Group and NewsBios and remain proprietary to TJFR Group and NewsBios.  TJFR reserves its entire right, title and interest in and to the Database ( NewsBios) and all Intellectual Property Rights therein.